glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Promises of Protein Kinase Inhibitors
Promises of Protein Kinase Inhibitors in Recalcitrant Small Cell Lung Cancer: Recent Scenario and Future Possibilities Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Inhibiting the system xC glutathione axis selectively targets cancers with mutant p53 accumulation Nature Communications Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect
Pay in 4 interest-free payments of $6.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



